3 million Canadians use GLP-1 drugs. Survey says that's changing their appetites — and habits
A new survey suggests about three million Canadian adults are currently taking GLP-1 drugs such as Ozempic or Mounjaro and that many more would like to, but cost is a barrier.
Related Posts
First Nation seeks federal funding to support first on-reserve birthing lodge in Sask.
Documents show Horizon staff raised alarm about ambulance bay unit long before public backlash
